Skip to main contentSkip to navigation
Sirius Investors

AFJK Stock: Aimei Health Technology Co., Ltd Stock Price, Analysis & Insights

Get live afjk stock price $21.80, comprehensive Aimei Health Technology Co., Ltd stock analysis, charts, news, and expert forecast. Real-time afjk stock data and investment insights.

21.80
60.89%Today
AFJKAimei Health Technology Co., Ltd • NASDAQ • Financial Services
Market Cap
133.45M
Volume
247.43K
52W High
41.80
52W Low
10.20
Upgrade to Pro or Premium to access long-term historical data (3M, 6M, 1Y, 2Y, 5Y, 10Y, Max)

Loading chart...

Company Overview

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Company Information

CEO
Junheng Xie
Sector
Financial Services
Industry
Shell Companies
Employees
2

Contact Information

Website
Address
10 East 53rd Street
Country
US

Investment Analysis & Business Insights

Financial Services
Shell Companies

Investment Highlights

Strong presence in the Financial Services sector with established market position

Listed on major US exchange (NASDAQ) providing liquidity and transparency

Growth-oriented company with premium valuation (P/E: 99.1)

Lower volatility stock (Beta: -0.03) may provide portfolio stability

Business Model & Strategy

Aimei Health Technology Co., Ltd operates in the Shell Companies industry, focusing on financial intermediation, banking services, and investment management. Under the leadership of CEO Junheng Xie, the company navigates Financial Services sector dynamics while pursuing growth opportunities. The Shell Companies model requires risk management, regulatory compliance, and customer trust to maintain competitiveness and drive shareholder value.

Market Position & Competitive Landscape

Aimei Health Technology Co., Ltd competes in the Shell Companies within the broader Financial Services. With 133.5 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Financial Services is characterized by economic cycles, regulatory evolution, and digital transformation. As a publicly traded company on the NASDAQ, Aimei Health Technology Co., Ltd provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Aimei Health Technology Co., Ltd should consider industry-specific trends, competitive positioning, and Financial Services sector fundamentals.

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Aimei Health Technology Co., Ltd shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Financial Services may affect company performance
  • Past performance does not guarantee future results for Aimei Health Technology Co., Ltd
  • Investors should consider how Aimei Health Technology Co., Ltd fits within their overall portfolio allocation
  • Premium valuation (P/E: 99.1) requires strong growth to justify

Market Cap

133.45M

P/E Ratio

99.09

Beta

-0.03

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Financial Services leader with 133.45M market capitalization
  • Trading Volume: 247.43K shares traded today
  • Price Range: 52-week range of $10.20 - $41.80
  • Exchange: Listed on NASDAQ

Financial Metrics

P/E Ratio:99.09
EPS:$0.22
Beta:-0.03
Avg Volume:2.94K

Market Analysis for Aimei Health Technology Co., Ltd

Aimei Health Technology Co., Ltd (AFJK) operates in the Shell Companies industry within the Financial Services sector. With a current market capitalization of 133.45M, the company represents a significant player in its market. The stock is currently trading at $21.80 with a positivedaily change of 60.89%.

The company's 2 employee base and presence on the NASDAQexchange position it as a Financial Services sector leader. Investors should consider the stock's P/E ratio of 99.09, beta of -0.03, and 52-week price range from $10.20 to $41.80when evaluating investment opportunities.

Why Invest in Aimei Health Technology Co., Ltd?

Strengths
  • • Established market presence in Financial Services
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ)
  • • Experienced leadership under Junheng Xie
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Financial Services Stocks

About Financial Services Sector

The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.